1. Home
  2. MBIN vs BHVN Comparison

MBIN vs BHVN Comparison

Compare MBIN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

HOLD

Current Price

$53.42

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.49

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
BHVN
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
MBIN
BHVN
Price
$53.42
$13.49
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
$43.67
$29.08
AVG Volume (30 Days)
147.0K
1.8M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
26.08
EPS
2.73
N/A
Revenue
N/A
N/A
Revenue This Year
$31.76
N/A
Revenue Next Year
$3.73
N/A
P/E Ratio
$19.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.37
$7.48
52 Week High
$56.87
$18.57

Technical Indicators

Market Signals
Indicator
MBIN
BHVN
Relative Strength Index (RSI) 52.83 N/A
Support Level $52.89 N/A
Resistance Level $56.87 N/A
Average True Range (ATR) 1.23 0.00
MACD -0.29 0.00
Stochastic Oscillator 9.66 0.00

Price Performance

Historical Comparison
MBIN
BHVN

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: